Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients-Reference-Cited by-同舟云学术

Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients

Published:2017-09-21 Issue:48 Volume:8 Page:84180-84192
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Herlemann Annika¹,Kretschmer Alexander¹,Buchner Alexander¹²,Karl Alexander¹²,Tritschler Stefan¹²,El-Malazi Lina¹,Fendler Wolfgang P.³,Wenter Vera³,Ilhan Harun³,Bartenstein Peter²³,Stief Christian G.¹²,Gratzke Christian¹²

Affiliation:

1. Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany

2. Comprehensive Cancer Center, Ludwig-Maximilians-University of Munich, Munich, Germany

3. Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support;World Journal of Urology;2023-07-29

2. Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy;Cancer Imaging;2023-03-17

3. Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer—A Systematic Review;European Urology Oncology;2023-02

4. Necessity of Pelvic Lymph Node Irradiation in Patients with Recurrent Prostate Cancer after Radical Prostatectomy in the PSMA PET/CT Era: A Narrative Review;Biomedicines;2022-12-24

5. The current role of precision surgery in oligometastatic prostate cancer;ESMO Open;2022-12